<DOC>
	<DOCNO>NCT01823965</DOCNO>
	<brief_summary>In prospective monocentric open label trial patient diabetic macular edema treat intravitreal injection ranibizumab give 3 month laser grid month 4 . During follow-up ranibizumab injection perform every 2 month case best-corrected visual acuity decrease 5 letter .</brief_summary>
	<brief_title>Intravitreal Injections Ranibizumab With Deferred Laser Grid Laser Photocoagulation Treatment Diabetic Macular Edema With Visual Impairment</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>diabetes mellitus ( 1 or2 ) decrease vision Diabetic Macular Edema ( study eye Best Corrected Visual Acuity &lt; 69 letter use E.T.D.R.S test ) macular edema history severe cardiac disease stroke within 12 month intraocular inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>